TABLE 2

EFV concentration (nanograms per milliliter) in MP, BM, and IP over 6 months postpartum

Values are presented as the median (IQR) of individual ratios, n (the number of samples available for analysis, of a possible 32 samples; missing samples due to shipping error), unless otherwise noted.

Study VisitMPaBMbIPcBM/MP RatioIP/MP RatioRelative Infant Dose
%
Month 12930 (2450–6595), n = 224660 (2940–7660), n = 22347 (282–573), n = 221.11 (0.89–1.73), n = 190.057 (0.03–0.11), n = 20
Month 33050 (2060–6685), n = 314160 (1900–6440), n = 31268 (142–465), n = 301.06 (0.86–1.63), n = 300.072 (0.05–0.09), n = 28
Month 62740 (2150–8080), n = 303920 (2570–9350), n = 30175 (90–331), n = 301.27 (0.96–1.50), n = 280.048 (0.03–0.07), n = 242.46
  • a MP EFV was below the LOQ in one sample each at months 1, 3, and 6.

  • b BM EFV was below LOQ in one sample at months 1 and 3, and in two samples at months 6.

  • c IP EFV was below LOQ in one, two, and three samples at months 1, 3, and 6, respectively.